|
Income Statement for
CAS Medical Systems Inc.
(CASM)
|
|
|
|
|
|
|
| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
22,669 |
22,451 |
24,086 |
25,041 |
40,649 |
| Total Revenue |
22,669 |
22,451 |
24,086 |
25,041 |
40,649 |
| Adjustments to Revenue |
N/A |
N/A |
- |
- |
- |
| Cost of Revenue |
12,604 |
13,893 |
13,168 |
13,817 |
25,713 |
| Cost of Sales With Depreciation |
13,565 |
13,893 |
14,128 |
14,753 |
26,748 |
| Gross Margin |
9,104 |
8,558 |
10,918 |
11,224 |
14,936 |
| Gross Operating Profit |
9,104 |
8,558 |
10,918 |
11,224 |
14,936 |
|
| Selling/General/Admin Expense |
(12,529) |
(11,510) |
(9,957) |
(11,274) |
(12,165) |
| Research & Development |
(4,020) |
(3,525) |
(1,689) |
(2,443) |
(2,028) |
| Advertising |
- |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
(7,406) |
(6,423) |
(728) |
(2,493) |
743 |
| Depreciation & Amortization |
(961) |
- |
(960) |
(936) |
(1,035) |
| Depreciation, Unreconciled |
- |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
- |
| Operating Income |
(7,300) |
(5,535) |
(1,688) |
(3,429) |
(291) |
| Operating Profit After Depreciation |
(7,300) |
(5,535) |
(1,688) |
(3,429) |
(291) |
| Interest Income |
- |
- |
- |
- |
- |
| Earnings from Equity Interest |
- |
- |
- |
- |
- |
| Other Income, Net |
39 |
53 |
- |
- |
- |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
(7,406) |
(6,423) |
(1,688) |
(3,429) |
(291) |
| Interest Expense |
(114) |
(27) |
(60) |
(103) |
(272) |
| Income Before Tax |
(7,519) |
(6,450) |
(1,748) |
(3,532) |
(564) |
| Income Taxes |
211 |
125 |
148 |
(179) |
176 |
| Minority Interest |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Other Special Charges |
(7,519) |
(6,450) |
(1,748) |
(3,532) |
(564) |
| Net Income from Continuing Operations |
(7,308) |
(6,325) |
(1,600) |
(3,710) |
(388) |
| Net Income from Discontinued Operations |
- |
242 |
295 |
(2,079) |
- |
| Net Income from Total Operations |
(7,308) |
(6,083) |
(1,305) |
(5,790) |
(388) |
|
| Normalized Income |
(7,308) |
(6,325) |
(1,600) |
(3,710) |
(388) |
| Extraordinary Income/Loss |
- |
- |
- |
- |
- |
| Special Income/Charges |
- |
- |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
- |
| Net Income Available for Common |
(8,432) |
(6,956) |
(1,600) |
(3,710) |
(388) |
| Other Gains |
- |
- |
- |
- |
- |
| Total Net Income |
(7,308) |
(6,083) |
(1,305) |
(5,790) |
(388) |
| Net Income Available for Common |
(8,432) |
(6,956) |
(1,600) |
(3,710) |
(388) |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Preferred Dividends |
1,123 |
631 |
- |
- |
- |
| Basic EPS from Continuing Operations |
-0.63 |
-0.53 |
-0.13 |
-0.33 |
-0.04 |
| Basic EPS from Discontinued Operations |
0.00 |
0.02 |
0.02 |
-0.18 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
-0.63 |
-0.51 |
-0.11 |
-0.51 |
-0.04 |
| Basic Normalized Net Income per Share |
-0.63 |
-0.53 |
-0.13 |
-0.33 |
-0.04 |
| Basic EPS from Total Operations |
-0.63 |
-0.51 |
-0.11 |
-0.51 |
-0.04 |
|
| Diluted EPS from Continuing Operations |
-0.63 |
-0.53 |
-0.13 |
-0.33 |
-0.04 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.02 |
0.02 |
-0.18 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
-0.63 |
-0.51 |
-0.11 |
-0.51 |
-0.04 |
| Diluted Normalized Net Income per Share |
-0.63 |
-0.53 |
-0.13 |
-0.33 |
-0.04 |
| Excise Tax |
- |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
-0.63 |
-0.51 |
-0.11 |
-0.51 |
-0.04 |
|
|
|
